搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Globe and Mail
1 小时
Could This Near Trillion-Dollar Stock Be a Millionaire Maker?
Retatrutide mimics the action of three hormones: GLP-1, GIP, and glucagon. Eli Lilly is calling it triple G. Meanwhile, the ...
BioWorld
4 小时
Boston Sci study shows Watchman Flx better OPTION than DOAC
Boston Scientific Corp.’s OPTION study demonstrated left atrial appendage closure with the Watchman Flx device reduced risk of stroke compared to management with direct oral anticoagulants or warfarin ...
MedPage Today
6 小时
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy
More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
kpvi
12 小时
Diabetes Meds Metformin, GLP-1s Can Also Curb Asthma
"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...
12 小时
Nasal spray version of common diuretic has potential to help treat heart failure
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...
14 小时
The first MASH drug could open the door for others — including GLP-1s
With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈